<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.diabesityrounds.com/a/litmus-somasignal-panel-most-accurate-for-at-risk-mash-and-advanced-fibrosis</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T20:32:46.373Z</news:publication_date><news:title>LITMUS: SomaSignal panel most accurate for at-risk MASH and advanced fibrosis</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/statstrip-gen-2-0-hospital-glucose-meter-recall-results-may-go-to-wrong-patient</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T20:17:20.680Z</news:publication_date><news:title>StatStrip Gen 2.0 hospital glucose meter recall: results may go to wrong patient</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-phase-iii-trial-of-degludec-aspart-mix-recommended</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T20:02:26.360Z</news:publication_date><news:title>CDSCO expert committee: Phase III trial of degludec/aspart mix recommended</news:title></news:news></url></urlset>